anti-ribonucleoprotein antibody ATRC-101

An engineered, human immunoglobulin (Ig) G1 monoclonal antibody directed against a ribonucleoprotein (RNP) complex, with potential immunostimulating and antineoplastic activities. Upon administration, anti-RNP antibody ATRC-101 targets and binds to its RNP complex antigen on tumor cells. This may activate the innate immune system, change the local tumor microenvironment (TME) and promote T-cell-mediated killing of tumor cells. The tumor-restricted RNP complex is expressed in a variety of tumor cells.